First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2 意见
• 07/03/23
0
0
嵌入
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论